ArticleMovement disorders : official journal of the Movement Disorder Society2024

Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease.

John D Heiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.